Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IDH2 inhibition in AML: Finally progress?
    Journal Article

    Stein, E. M.
    Best Practice and Research: Clinical Haematology (2015)

    Fulltext@MSK | Save
  • Overcoming antigen escape with CAR T-cell therapy
    Journal Article

    Jackson, H. J.; Brentjens, R. J.
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
    Journal Article

    Zhang, L.; Tran, N. T.; Su, H.; Wang, R.; Lu, Y.; Tang, H.; Aoyagi, S.; Guo, A.; Khodadadi-Jamayran, A.; Zhou, D.; more...
    eLife (2015)

    Fulltext@MSK | Save
  • DH2 inhibitors in acute myeloid leukemia
    Meeting Abstract

    Coombs, C. C.; Stein, E. M.; Levine, R. L.; Tallman, M. S.
    Annals of Hematology (2015)

    Fulltext@MSK | Save
  • Significance of novel gene mutations in AML
    Meeting Abstract

    Shih, A.; Jiang, Y.; Meydan, C.; Melnick, A.; Levine, R.
    Annals of Hematology (2015)

    Fulltext@MSK | Save
  • Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Journal Article

    Viny, A. D.; Ott, C. J.; Spitzer, B.; Rivas, M.; Meydan, C.; Papalexi, E.; Yelin, D.; Shank, K.; Reyes, J.; Chiu, A.; more...
    Journal of Experimental Medicine (2015)

    Fulltext@MSK | Save
  • IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo
    Journal Article

    Koneru, M.; Purdon, T. J.; Spriggs, D.; Koneru, S.; Brentjens, R. J.
    OncoImmunology (2015)

    Fulltext@MSK | Save
  • Cost-effectiveness analysis of treating acute promyelocytic leukemia patients with arsenic trioxide and retinoic acid in the United States
    Journal Article

    Tallman, M.; Lo-Coco, F.; Barnes, G.; Kruse, M.; Wildner, R.; Martin, M.; Mueller, U.; Tang, B.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia: Past, present and future
    Journal Article

    Getta, B. M.; Park, J. H.; Tallman, M. S.
    Best Practice and Research: Clinical Haematology (2015)

    Fulltext@MSK | Save
  • Prolonged survival in patients >= 60 years with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 VALOR study
    Meeting Abstract

    Krug, U.; Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; more...
    Oncology Research and Treatment (2015)

    Fulltext@MSK | Save